Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
Company linked to Michelle Mone owes £39m in unpaid taxes
5/11/2025
Resident doctors’ strike to go ahead after Wes Streeting’s last-ditch offer is rejected
5/11/2025
Nine-month-old baby killed by XL bully, Gwent police confirm
5/11/2025
Andrew allowed to keep Falklands medal despite losing royal and military titles
5/11/2025
London mayor sees parallels in Zohran Mamdani’s victory : ‘Hope won’
5/11/2025
Ella Baron on Zohran Mamdani’s New York City mayoral victory – cartoon
5/11/2025